FindTrial
Sign In

The long-term effecs of COVID-19 after Qingfei paidu decoction treatment in acute phase: a retrospective cohort study

The long-term effecs of COVID-19 after Qingfei paidu decoction treatment in acute phase: a retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045787
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Qingfeipaidu Decoction group:Nil
Without Any Traditionl Chinese Herbs:Nil

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.In line with the diagnostic criteria for New Coronavirus infection (trial version sixth); 2.Aged > 18 years; 3.Patients informed consent; 4.There were fatigue, headache, attention disorder, hair loss, dyspnea, mental disorders and other sequelae, and the duration was more than 6 months.

Exclusion criteria

Exclusion criteria: 1.Those who are combined with severe mental illness, mental disorder or sedation; 2.Those who suffer fatal co-morbidities within the study follow-up period.

Design outcomes

Primary

MeasureTime frame
Recovery Rate;—

Countries

China

Contacts

Public ContactFan Rong

Xiangya Hospital, Central South University

fanrong3463@163.com+86 13808454319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026